共 200 条
- [11] Todorova L(2016)Liver transplantation and the management of progressive familial intrahepatic cholestasis in children World J Transplant 6 278-290
- [12] Kerkar N(2017)Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: an ISPOR COA Emerging Good Practices Task Force report Value Health 20 838-855
- [13] Sundaram SS(2015)Clinical outcome assessments: conceptual foundation-report of the ISPOR Clinical Outcomes Assessment—Emerging Good Practices for Outcomes Research Task Force Value Health 18 741-752
- [14] Mack CL(2011)Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 1–eliciting concepts for a new PRO instrument Value Health 14 967-977
- [15] Feldman AG(2011)Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2–assessing respondent understanding Value Health 14 978-988
- [16] Sokol RJ(2018)Biliary atresia: clinical and research challenges for the twenty-first century Hepatology 68 1163-1173
- [17] Turnpenny PD(2017)Qualitative methods and patient-reported outcomes: measures development and adaptation Int J Qual Methods 16 1-3
- [18] Ellard S(2012)Using pruritus grading system for measurement of pruritus in patients with diseases associated with itch J Med J 46 39-44
- [19] Thébaut A(2009)Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool Br J Dermatol 161 1143-1148
- [20] Debray D(2001)New aspects of itch pathophysiology: component analysis of atopic itch using the 'Eppendorf Itch Questionnaire' Int Arch Allergy Immunol 124 326-331